National Pension Service boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 0.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 477,200 shares of the company’s stock after buying an additional 414 shares during the period. National Pension Service’s holdings in Cardinal Health were worth $52,740,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of CAH. Eastern Bank purchased a new position in shares of Cardinal Health during the third quarter valued at $25,000. Cultivar Capital Inc. bought a new position in Cardinal Health during the 2nd quarter worth about $27,000. Ashton Thomas Private Wealth LLC purchased a new position in Cardinal Health during the 2nd quarter valued at about $29,000. LRI Investments LLC bought a new stake in shares of Cardinal Health in the 1st quarter valued at about $32,000. Finally, New Covenant Trust Company N.A. purchased a new stake in shares of Cardinal Health in the 1st quarter worth approximately $40,000. 87.17% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, CEO Jason M. Hollar sold 26,716 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $108.87, for a total transaction of $2,908,570.92. Following the sale, the chief executive officer now directly owns 244,091 shares in the company, valued at $26,574,187.17. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Cardinal Health news, CEO Jason M. Hollar sold 46,455 shares of the stock in a transaction on Monday, August 19th. The shares were sold at an average price of $109.02, for a total transaction of $5,064,524.10. Following the transaction, the chief executive officer now directly owns 197,636 shares of the company’s stock, valued at $21,546,276.72. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jason M. Hollar sold 26,716 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $108.87, for a total transaction of $2,908,570.92. Following the sale, the chief executive officer now directly owns 244,091 shares of the company’s stock, valued at $26,574,187.17. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 113,963 shares of company stock worth $12,379,980. Company insiders own 0.09% of the company’s stock.
Cardinal Health Stock Performance
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.73 earnings per share. Analysts forecast that Cardinal Health, Inc. will post 7.69 EPS for the current year.
Cardinal Health Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.79%. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.
Analysts Set New Price Targets
A number of research firms have recently weighed in on CAH. Deutsche Bank Aktiengesellschaft raised their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday. Morgan Stanley raised their price objective on Cardinal Health from $119.00 to $127.00 and gave the stock an “overweight” rating in a research report on Monday. Robert W. Baird increased their price target on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Citigroup dropped their price target on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a research note on Friday, July 19th. Finally, Mizuho increased their price objective on shares of Cardinal Health from $110.00 to $120.00 and gave the company a “neutral” rating in a research report on Monday. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $123.00.
View Our Latest Research Report on Cardinal Health
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
- Five stocks we like better than Cardinal Health
- Compound Interest and Why It Matters When Investing
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to buy stock: A step-by-step guide for beginners
- Insider Buying Signals Upside for These 3 Stocks
- What is the S&P/TSX Index?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.